104.851 articles found

Production and perception of emotional prosody : the case of autism and Parkinson's disease

Hsu CCT.

· 2016-01-01

Characterization of Parkinson's disease-associated LRRK2 kinase

Katsemonova K.

· 2016-01-01

Continuous L-DOPA secretion by AAV gene therapy to improve the treatment of Parkinson's disease

Antunes ASLM.

· 2016-01-01

Parkinsonlu Bireylerde Müzik Eşliğinde Ritmik Hareket Tedavisinin Günlük Yaşam Aktivitelerindeki Bağımsızlık ve Aktivite Performansına Etkisi

Öz, Zeynep, Akı, Esra

Ergoterapi ve Rehabilitasyon Dergisi, Vol. 4 No. 1 · 2016-01-01

Episodic Memory in Alzheimer Disease, Frontotemporal Dementia, and Dementia With Lewy Bodies/Parkinson Disease Dementia: Disentangling Retrieval From Consolidation.

Economou A, Routsis C, Papageorgiou SG.

Alzheimer Dis Assoc Disord · 2016-01-01

DOI: 10.1097/wad.0000000000000089PMID: 25730300

An Update on Human Stem Cell-Based Therapy in Parkinson's Disease.

González C, Bonilla S, Flores AI, Cano E, Liste I.

Curr Stem Cell Res Ther · 2016-01-01

DOI: 10.2174/1574888x10666150531172612PMID: 26027681

Association Between Sagittal Balance and Scoliosis in Patients with Parkinson Disease: A Cross-sectional Study.

Bissolotti L, Donzelli S, Gobbo M, Zaina F, Villafañe JH, Negrini S.

Am J Phys Med Rehabil · 2016-01-01

DOI: 10.1097/phm.0000000000000328PMID: 26062043

PAX6 expression may be protective against dopaminergic cell loss in Parkinson's disease.

Thomas MG, Welch C, Stone L, Allan P, Barker RA, White RB.

CNS Neurol Disord Drug Targets · 2016-01-01

DOI: 10.2174/1871527314666150821101757PMID: 26295830

Lower Frequency of co-Morbid Medical Disorders Related to Poor Impulse Control in Parkinson's than Alzheimer's Disease.

Saito EK, Diaz N, Morrow J, Chung J, McMurtray A.

Curr Aging Sci · 2016-01-01

DOI: 10.2174/1874609808666150923151943PMID: 26412353

Perinatal 6-Hydroxydopamine to Produce a Lifelong Model of Severe Parkinson's Disease.

Kostrzewa JP, Kostrzewa RA, Kostrzewa RM, Brus R, Nowak P.

Curr Top Behav Neurosci · 2016-01-01

DOI: 10.1007/7854_2015_396PMID: 26475156

The pattern of gray matter atrophy in Parkinson's disease differs in cortical and subcortical regions.

Lewis MM, Du G, Lee EY, Nasralah Z, Sterling NW, Zhang L, Wagner D, Kong L, Tröster AI, Styner M, Eslinger PJ, Mailman RB, Huang X.

J Neurol · 2016-01-01

DOI: 10.1007/s00415-015-7929-7PMID: 26486354

Anti-Oxidants in Parkinson's Disease Therapy: A Critical Point of View.

Filograna R, Beltramini M, Bubacco L, Bisaglia M.

Curr Neuropharmacol · 2016-01-01

DOI: 10.2174/1570159x13666151030102718PMID: 26517052